EURAD
examines Harm Reduction
Brief Claims and Replies
A EURAD Think Tank Production partially funded by the European Commission
This EURAD document about certain aspects of Harm Reduction is designed to teach. It reflects EURAD's standpoint which is an extremely cautious approach to methadone programmes and EURAD's scepticism towards needle distribution programmes.
This paper consists of two parts. Part one is a more general discussion regarding perspectives on harm reduction. Part two deals more specially with methadone and distribution of free needles/syringes.
Part ONE
- Introduction
- Complications
- Legalisation - Harm Reduction - Background
- Eurad drug policy
Part TWO
- Methadone - Important to know
- Strict Programme
- What can EURAD advise about methadone?
- Needle/Syringe distribution
- What can EURAD advise about needles/syringes?
 |
